These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 15193381

  • 1. Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challenge.
    Heineman TC, Pesnicak L, Ali MA, Krogmann T, Krudwig N, Cohen JI.
    Vaccine; 2004 Jun 30; 22(20):2558-65. PubMed ID: 15193381
    [Abstract] [Full Text] [Related]

  • 2. Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs.
    Heineman TC, Connelly BL, Bourne N, Stanberry LR, Cohen J.
    J Virol; 1995 Dec 30; 69(12):8109-13. PubMed ID: 7494331
    [Abstract] [Full Text] [Related]

  • 3. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.
    Bourne N, Bravo FJ, Francotte M, Bernstein DI, Myers MG, Slaoui M, Stanberry LR.
    J Infect Dis; 2003 Feb 15; 187(4):542-9. PubMed ID: 12599070
    [Abstract] [Full Text] [Related]

  • 4. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
    Awasthi S, Mahairas GG, Shaw CE, Huang ML, Koelle DM, Posavad C, Corey L, Friedman HM.
    J Virol; 2015 Aug 15; 89(16):8497-509. PubMed ID: 26041292
    [Abstract] [Full Text] [Related]

  • 5. Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine.
    Kohl S, Charlebois ED, Sigouroudinia M, Goldbeck C, Hartog K, Sekulovich RE, Langenberg AG, Burke RL.
    J Infect Dis; 2000 Jan 15; 181(1):335-9. PubMed ID: 10608784
    [Abstract] [Full Text] [Related]

  • 6. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2.
    Quenelle DC, Collins DJ, Marciani DJ, Kern ER.
    Vaccine; 2006 Mar 06; 24(10):1515-22. PubMed ID: 16288820
    [Abstract] [Full Text] [Related]

  • 7. Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes.
    Bernstein DI, Cardin RD, Bravo FJ, Hamouda T, Pullum DA, Cohen G, Bitko V, Fattom A.
    Vaccine; 2019 Oct 08; 37(43):6470-6477. PubMed ID: 31515143
    [Abstract] [Full Text] [Related]

  • 8. Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected.
    Bourne N, Milligan GN, Stanberry LR, Stegall R, Pyles RB.
    J Infect Dis; 2005 Dec 15; 192(12):2117-23. PubMed ID: 16288376
    [Abstract] [Full Text] [Related]

  • 9. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease.
    Da Costa XJ, Bourne N, Stanberry LR, Knipe DM.
    Virology; 1997 May 26; 232(1):1-12. PubMed ID: 9185583
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits.
    Nesburn AB, Burke RL, Ghiasi H, Slanina SM, Wechsler SL.
    Virology; 1998 Dec 05; 252(1):200-9. PubMed ID: 9875329
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs.
    Awasthi S, Balliet JW, Flynn JA, Lubinski JM, Shaw CE, DiStefano DJ, Cai M, Brown M, Smith JF, Kowalski R, Swoyer R, Galli J, Copeland V, Rios S, Davidson RC, Salnikova M, Kingsley S, Bryan J, Casimiro DR, Friedman HM.
    J Virol; 2014 Feb 05; 88(4):2000-10. PubMed ID: 24284325
    [Abstract] [Full Text] [Related]

  • 13. Cervical antibody responses to a herpes simplex virus type 2 glycoprotein subunit vaccine.
    Ashley RL, Crisostomo FM, Doss M, Sekulovich RE, Burke RL, Shaughnessy M, Corey L, Polissar NL, Langenberg AG.
    J Infect Dis; 1998 Jul 05; 178(1):1-7. PubMed ID: 9652416
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
    Fotouhi F, Soleimanjahi H, Roostaee MH, Behzadian F.
    FEMS Immunol Med Microbiol; 2008 Oct 05; 54(1):18-26. PubMed ID: 18647350
    [Abstract] [Full Text] [Related]

  • 15. Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.
    Hook LM, Cairns TM, Awasthi S, Brooks BD, Ditto NT, Eisenberg RJ, Cohen GH, Friedman HM.
    PLoS Pathog; 2018 May 05; 14(5):e1007095. PubMed ID: 29791513
    [Abstract] [Full Text] [Related]

  • 16. Herpes simplex virus DNA vaccine efficacy: effect of glycoprotein D plasmid constructs.
    Strasser JE, Arnold RL, Pachuk C, Higgins TJ, Bernstein DI.
    J Infect Dis; 2000 Nov 05; 182(5):1304-10. PubMed ID: 11023454
    [Abstract] [Full Text] [Related]

  • 17. Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs.
    Hoshino Y, Pesnicak L, Dowdell KC, Burbelo PD, Knipe DM, Straus SE, Cohen JI.
    J Infect Dis; 2009 Oct 01; 200(7):1088-95. PubMed ID: 19702506
    [Abstract] [Full Text] [Related]

  • 18. A herpes simplex virus 2 (HSV-2) glycoprotein D-expressing nonreplicating dominant-negative HSV-2 virus vaccine is superior to a gD2 subunit vaccine against HSV-2 genital infection in guinea pigs.
    Zhang P, Xie L, Balliet JW, Casimiro DR, Yao F.
    PLoS One; 2014 Oct 01; 9(6):e101373. PubMed ID: 24979708
    [Abstract] [Full Text] [Related]

  • 19. Maternal immunization with a herpes simplex virus type 2 replication-defective virus reduces visceral dissemination but not lethal encephalitis in newborn mice after oral challenge.
    Evans IA, Jones CA.
    J Infect Dis; 2002 Jun 01; 185(11):1550-60. PubMed ID: 12023760
    [Abstract] [Full Text] [Related]

  • 20. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
    Tengvall S, O'Hagan D, Harandi AM.
    Antiviral Res; 2008 Jun 01; 78(3):202-14. PubMed ID: 18276020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.